GO:0003162 atrioventricular node development: Origin, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003162 describes the developmental process that builds the atrioventricular (AV) node, the cardiac conduction system component that delays electrical signals between atria and ventricles.
• The AV node arises from embryonic heart regions including the atrioventricular canal myocardium and is characterized by slow conduction, automaticity, and a distinct connexin expression profile.
• Key transcription factors such as GATA6 and TBX3, together with signaling pathways like RHOA-ROCK, regulate AV node development and function.
• Disruption of AV node development or its genetic program causes atrioventricular block, arrhythmias, and conduction defects in humans and animal models.
• Modern research uses electrophysiology, lineage tracing, single-cell transcriptomics, and CRISPR-based models to dissect AV node development.
• EDITGENE provides knockout, point-mutation, knock-in, overexpression cell models and CRISPR library screening to study genes involved in AV node development.
Description
The atrioventricular (AV) node is a specialized cluster of cardiomyocytes within the cardiac conduction system that receives electrical impulses from the sinoatrial node and relays them to the His-Purkinje system, thereby controlling the timing of ventricular contraction. The Gene Ontology term GO:0003162, atrioventricular node development, defines the biological process by which this node progresses from its formation to its mature structure. Understanding AV node development is critical because congenital or acquired abnormalities in this process underlie life-threatening arrhythmias and conduction blocks. Research into AV node development spans embryology, molecular genetics, and electrophysiology, with model organisms such as chick, mouse, and human induced pluripotent stem cell-derived cardiomyocytes providing key insights. The AV node is anatomically and molecularly distinct from working myocardium, exhibiting slow conduction, automaticity, and a unique connexin repertoire. These features emerge during development through tightly regulated transcriptional programs and signaling pathways. Consequently, GO:0003162 serves as a central annotation for genes and pathways that orchestrate the formation of this vital pacemaking and conduction structure.
atrioventricular node development At A Glance
| GO ID | GO:0003162 |
|---|---|
| GO term | atrioventricular node development |
| Ontology | biological_process |
| Synonym | AV node development |
| Major function | Formation and maturation of the AV node, enabling delayed electrical conduction from atria to ventricles |
| Anatomical location | Atrioventricular junction of the heart, part of the cardiac conduction system |
| Key cell types | Specialized cardiomyocytes of the AV node, including pacemaker-like cells |
| Related processes | Cardiac conduction, heart development, sinoatrial node development, His-Purkinje system development |
What Is GO:0003162?
GO:0003162, atrioventricular node development, is the biological process whose specific outcome is the progression of the AV node over time, from its initial formation to its mature structure. The AV node is part of the cardiac conduction system that controls the timing of ventricle contraction by receiving electrical signals from the sinoatrial node and relaying them to the His-Purkinje system.
Why Is atrioventricular node development Important in Cell Biology?
AV node development is essential for normal heart rhythm and coordinated contraction; defects in this process lead to atrioventricular block, arrhythmias, and heart failure, making it a key area for understanding congenital and acquired conduction disorders.
• The AV node provides the only normal electrical connection between atria and ventricles, and its developmental failure causes heart block.
• Congenital mutations in genes regulating AV node development are associated with familial atrioventricular block and arrhythmias.
• AV node dysfunction is a major cause of bradycardia and is treated with pacemakers or AV node ablation in atrial fibrillation.
• Understanding AV node development informs regenerative strategies for biological pacemakers.
• The AV node has unique electrophysiological properties, including slow conduction and automaticity, which depend on its developmental gene program.
• Key transcription factors like GATA6 and TBX3 are critical for AV node development and function.
• Signaling pathways such as RHOA-ROCK regulate the development of the putative AV node and are linked to AV block.
• Animal models, especially chick and mouse embryos, have elucidated the morphological and electrophysiological steps of AV node development.
• Single-cell transcriptomics has revealed heterogeneity within the postnatal conduction system, including AV node cells.
• CRISPR-based gene editing enables functional testing of candidate genes in AV node development and disease.
What Happens During atrioventricular node development?
Specification of the AV node lineage
In simple terms: Certain heart cells are told to become AV node cells instead of ordinary heart muscle.
During early heart development, a subset of cardiomyocytes at the atrioventricular canal becomes specified to form the AV node. This specification involves the expression of transcription factors such as TBX3 and GATA6, which repress working myocardial genes and activate conduction-specific genes. Lineage tracing studies in chick embryos have shown that AV node precursors originate from the atrioventricular canal and possibly from the dorsal mesenchymal protrusion.
Morphogenesis and anatomical integration
In simple terms: The AV node cells organize into a distinct structure that connects the atria and ventricles.
As development proceeds, the AV node primordium undergoes morphological changes to form a compact node embedded in the atrioventricular junction. It becomes anatomically integrated with the His bundle and the atrial myocardium, establishing the conduction pathway. In the embryonic chick heart, electrophysiological studies have recorded the emergence of AV node function coinciding with its morphological differentiation.
Electrophysiological maturation
In simple terms: The AV node acquires the ability to conduct electrical signals slowly and to generate its own rhythm.
Maturation of the AV node involves the acquisition of slow conduction and automaticity, which are essential for its role in delaying ventricular activation. These properties arise from the expression of specific ion channels and connexins, such as connexin40 and connexin45, and the downregulation of connexin43. Electrophysiological recordings in chick embryos demonstrate that AV node cells develop action potential characteristics distinct from working myocardium.
Transcriptional and signaling regulation
In simple terms: A network of genes and signals controls how the AV node forms and works.
The development of the AV node is regulated by a complex transcriptional network. GATA6 is required for AV node development and function, as its disruption leads to conduction defects in mice. The RHOA-ROCK signaling pathway also plays a role; disruption of RHOA-ROCK signaling results in atrioventricular block and disturbed development of the putative AV node. Postnatal maturation of the conduction system involves further transcriptional changes that establish heterogeneity among AV node cells.
Key Genes Involved in GO:0003162 atrioventricular node development
The following genes have been experimentally implicated in atrioventricular node development and function, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GATA6 | Transcription factor required for AV node development and function | Knockout causes AV conduction defects; studied in mouse models |
| TBX3 | Transcription factor marking the AV node lineage and repressing working myocardial genes | Key marker of AV node specification; used in lineage tracing |
| TBX2 | Transcription factor involved in AV canal patterning | Cooperates with TBX3 in conduction system development |
| NPPA | Natrieuretic peptide precursor A, expressed in AV node | Marker of chamber myocardium; its repression is important for AV node identity |
| GJA5 (Connexin40) | Gap junction protein contributing to fast conduction | Expressed in AV node; changes in expression affect conduction |
| GJA1 (Connexin43) | Major gap junction protein of working myocardium | Downregulated in AV node; its absence is critical for slow conduction |
| GJC1 (Connexin45) | Gap junction protein expressed in conduction system | Contributes to AV node conduction properties |
| RHOA | Small GTPase regulating cytoskeleton and signaling | Disruption of RHOA-ROCK signaling causes AV block and abnormal AV node development |
| ROCK1/2 | Downstream effectors of RHOA | Inhibition leads to AV conduction defects in models |
| HCN4 | Ion channel underlying pacemaker current If | Expressed in AV node; important for automaticity |
| CACNA1C | L-type calcium channel subunit | Mediates AV node action potential upstroke |
| SCN5A | Sodium channel subunit | Expressed in AV node; mutations linked to conduction disease |
| NKX2-5 | Homeobox transcription factor in heart development | Regulates conduction system genes; mutations cause AV block |
| ISL1 | Transcription factor in cardiac progenitors | Marks AV node progenitors in lineage studies |
| PITX2 | Transcription factor in left-right asymmetry | Associated with atrial fibrillation and AV node development |
| BMP2 | Signaling ligand in AV canal | Regulates AV node specification |
| WNT2 | Signaling ligand in AV canal | Involved in AV node development |
How Is atrioventricular node development Regulated?
The development of the atrioventricular node is regulated by a combination of transcriptional regulators, signaling pathways, and epigenetic factors. GATA6 acts as a key transcription factor, and its conditional deletion in mice leads to AV node hypoplasia and conduction defects. The RHOA-ROCK signaling pathway is also critical; pharmacological or genetic disruption of RHOA-ROCK results in atrioventricular block and abnormal development of the putative AV node in mouse models. Additionally, the postnatal maturation of the conduction system involves dynamic changes in gene expression, including transcription factors that establish AV node heterogeneity. The expression of specific connexins, such as connexin40 and connexin45, is tightly regulated during AV node development to achieve the characteristic slow conduction.
atrioventricular node development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GATA6 | Atrioventricular block, conduction defects | Cardiomyocyte-specific knockout mouse |
| RHOA | AV block, disturbed AV node development | Conditional knockout or pharmacological inhibition in mouse |
| SCN5A | Familial AV block, Brugada syndrome | Knock-in mouse or hiPSC-derived cardiomyocytes |
| NKX2-5 | Congenital heart disease with AV block | Knockout mouse and patient-derived iPSCs |
| TBX3 | Arrhythmia susceptibility, conduction system defects | Lineage tracing and knockout models |
Atrioventricular block and conduction disorders
Disruption of AV node development leads to atrioventricular block, a condition where electrical signals from the atria fail to reach the ventricles properly. In mice, conditional knockout of GATA6 results in AV conduction defects and abnormal AV node structure. Similarly, inhibition of RHOA-ROCK signaling causes AV block and disturbed development of the putative AV node. In humans, mutations in genes such as SCN5A and NKX2-5 are associated with familial AV block and conduction disease.
Atrial fibrillation and AV node ablation
The AV node is a therapeutic target in atrial fibrillation, where AV node ablation is used to control ventricular rate in patients refractory to other treatments. This procedure relies on understanding AV node anatomy and development. Developmental abnormalities of the AV node may predispose to arrhythmias, and genetic variants affecting AV node development have been linked to atrial fibrillation risk.
Congenital heart defects
Abnormal AV node development is often associated with congenital heart defects, particularly those involving the atrioventricular septum. Defects in the development of the AV node can result in complete heart block, which may require pacemaker implantation early in life.
From atrioventricular node development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate AV node development? | Knockout mouse or zebrafish |
| Does a specific point mutation in gene Y cause AV block? | Point-mutation knock-in mouse or hiPSCs |
| What is the effect of gene Z overexpression on AV node cells? | Overexpression in hiPSC-derived cardiomyocytes |
| Where and when is gene W expressed during AV node development? | Tagged knock-in reporter mouse or chick embryo |
| Which genes are essential for AV node lineage specification? | CRISPR library screening in differentiating hiPSCs |
| How does a disease-associated variant affect AV node function? | Patient-derived iPSCs with CRISPR correction |
How to Study the atrioventricular node development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Action potentials and ionic currents | Characterizing AV node cell automaticity |
| Optical mapping | Conduction velocity and activation patterns | Assessing AV node function in developing hearts |
| Single-cell RNA-seq | Transcriptomic heterogeneity | Identifying AV node cell subtypes |
| Lineage tracing | Cell fate and origin | Tracking AV node progenitors |
| Immunohistochemistry | Protein expression and localization | Detecting connexins and transcription factors |
| CRISPR knockout | Gene function loss | Testing requirement of genes in AV node development |
| CRISPR knock-in | Tagged or mutant protein expression | Visualizing AV node proteins or modeling mutations |
| ATAC-seq | Chromatin accessibility | Identifying regulatory regions in AV node development |
Electrophysiological mapping
Electrophysiological techniques, such as microelectrode recordings and optical mapping, are used to measure conduction properties and action potentials in the developing AV node. These methods have been applied in embryonic chick hearts to correlate morphological and functional development.
Lineage tracing and imaging
Genetic lineage tracing using Cre-lox systems in mice allows researchers to follow the fate of AV node progenitor cells. Combined with immunofluorescence and confocal imaging, these approaches reveal the anatomical integration of the AV node.
Transcriptomic profiling
Single-cell RNA sequencing and bulk RNA-seq have been used to characterize the transcriptome of the developing AV node and to identify novel markers and regulators. These studies highlight the heterogeneity of conduction system cells.
CRISPR-based functional genomics
CRISPR-Cas9 knockout, point mutation, and knock-in strategies enable precise testing of candidate genes in cell models and animal models. For example, knockout of GATA6 in mice confirmed its role in AV node development.
How CRISPR Can Be Used to Study GO:0003162 atrioventricular node development
Knockout
CRISPR-Cas9 knockout is used to delete candidate genes in cardiomyocyte models or animal embryos to assess their requirement for AV node development. For example, knockout of GATA6 in mice resulted in AV conduction defects and abnormal AV node structure.
Point Mutation
Point mutations identified in patients with AV block can be introduced into cell or animal models using CRISPR base editing or homology-directed repair. This allows researchers to determine whether a specific variant is causative for conduction disease.
Knock-in
Knock-in of reporter genes, such as fluorescent proteins, into AV node-specific loci enables lineage tracing and purification of AV node cells. This approach has been used to study the developmental origins of the AV node.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression can be used to test the effects of increased gene dosage on AV node development and function. Overexpression of TBX3, for instance, can reprogram working myocardium toward a conduction-like phenotype.
How EDITGENE Supports atrioventricular node development Research
Researchers studying atrioventricular node development-related genes often need to determine whether a candidate gene is causally involved in the process or is merely a bystander. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic perturbations in relevant cell models, accelerating functional validation and therapeutic target discovery.
Contact EDITGENE today to design your custom CRISPR model for atrioventricular node development research.
Frequently Asked Questions About atrioventricular node development
What is atrioventricular node development?
Atrioventricular node development (GO:0003162) is the biological process by which the AV node forms and matures, enabling delayed electrical conduction from the atria to the ventricles.
What genes are involved in atrioventricular node development?
Key genes include GATA6, TBX3, TBX2, NKX2-5, RHOA, and connexins such as GJA5 and GJC1.
What is the function of the AV node?
The AV node receives electrical signals from the sinoatrial node and relays them to the His-Purkinje system, controlling the timing of ventricular contraction.
How does the AV node develop?
The AV node develops from progenitor cells in the atrioventricular canal through specification, morphogenesis, and electrophysiological maturation, regulated by transcription factors and signaling pathways.
What diseases are associated with abnormal AV node development?
Abnormal AV node development is linked to atrioventricular block, congenital heart defects, and arrhythmias such as atrial fibrillation.
What animal models are used to study AV node development?
Chick embryos, mice, and zebrafish are commonly used, along with human induced pluripotent stem cell-derived cardiomyocytes.
How is GATA6 involved in AV node development?
GATA6 is a transcription factor required for AV node development; its knockout in mice causes AV conduction defects.
What is the role of connexins in the AV node?
Connexins such as connexin40 and connexin45 contribute to the unique electrical properties of the AV node, while connexin43 is downregulated.
Can CRISPR be used to study AV node development?
Yes, CRISPR knockout, knock-in, and point mutation models allow functional testing of genes in AV node development.
What research methods are used to study AV node development?
Methods include electrophysiology, lineage tracing, single-cell RNA-seq, and CRISPR screens.
Conclusion
Atrioventricular node development (GO:0003162) is a fundamental biological process that builds the cardiac conduction system's critical delay node. Research over decades has identified key transcriptional regulators, signaling pathways, and electrophysiological maturation steps, with GATA6 and RHOA-ROCK emerging as central players. Dysregulation of this process leads to atrioventricular block and other arrhythmias, highlighting its clinical importance. Modern CRISPR-based tools and multi-omics approaches are poised to uncover new regulators and therapeutic targets, and EDITGENE offers comprehensive services to support these efforts.
References
- 1. Bakker ML et al.. 2010. The atrioventricular node: origin, development, and genetic program.. Trends Cardiovasc Med 20(5):164-71 PMID: 21742272
- 2. Joza J et al.. 2024. Atrioventricular node ablation for atrial fibrillation in the era of conduction system pacing.. Eur Heart J 45(46):4887-4901 PMID: 39397777
- 3. Anderson RH et al.. 2009. The anatomy of the cardiac conduction system.. Clin Anat 22(1):99-113 PMID: 18773472
- 4. Temple IP et al.. 2013. Connexins and the atrioventricular node.. Heart Rhythm 10(2):297-304 PMID: 23085482
- 5. Liu F et al.. 2015. GATA-Binding Factor 6 Contributes to Atrioventricular Node Development and Function.. Circ Cardiovasc Genet 8(2):284-93 PMID: 25613430
- 6. Oh Y et al.. 2024. Transcriptional regulation of the postnatal cardiac conduction system heterogeneity.. Nat Commun 15(1):6550 PMID: 39095365
- 7. Argüello C et al.. 1988. The early development of the atrioventricular node and bundle of His in the embryonic chick heart. An electrophysiological and morphological study.. Development 102(3):623-37 PMID: 3181036
- 8. Kelder TP et al.. 2019. Disruption of RHOA-ROCK Signaling Results in Atrioventricular Block and Disturbed Development of the Putative Atrioventricular Node.. Anat Rec (Hoboken) 302(1):83-92 PMID: 30412368
